Clinical review of a long-acting, injectable formulation of risperidone.
about
Self-limiting Atypical Antipsychotics-induced Edema: Clinical Cases and Systematic ReviewIn vitro and in vivo demonstration of risperidone implants in mice.Dose-associated changes in safety and efficacy parameters observed in a 24-week maintenance trial of olanzapine long-acting injection in patients with schizophrenia.The role of long-acting injectable antipsychotics in schizophrenia: a critical appraisal.A rapid method for creating drug implants: translating laboratory-based methods into a scalable manufacturing processLong-acting injectable risperidone in partially adherent and nonadherent patients with schizophrenia.Peripheral Edema Occurring during Treatment with Risperidone Combined with Citalopram.Thirty-five months experience of risperidone long-acting injection in a UK psychiatric service including a mirror-image analysis of in-patient care.Risperidone long-acting injection: a review of its long term safety and efficacy.Hirsutism in a female adolescent induced by long-acting injectable risperidone: a case reportUse of long-acting risperidone in psychiatric disorders: focus on efficacy, safety and cost-effectiveness.Risperidone long-acting injection in the treatment of schizophrenia spectrum illnesses: A retrospective chart review of 19 patients in the Vancouver Community Mental Health Organization (Vancouver, Canada)Management of schizophrenia in children and adolescents: focus on pharmacotherapy.A review of paliperidone palmitate.Long-acting injectable formulations of antipsychotic drugs for the treatment of schizophrenia.Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for the management of schizophrenia and related disorders.Preparation, Characterization, and In Vivo Evaluation of Olanzapine Poly(D,L-lactide-co-glycolide) Microspheres.Development of Risperidone PLGA Microspheres.Patient perspectives on use of long-acting antipsychotics in bipolar disorder: focus on risperidone injection.Switching stable patients with schizophrenia from depot and oral antipsychotics to long-acting injectable risperidone: efficacy, quality of life and functional outcome.Experience with injectable long-acting risperidone in long-term therapy after an acute episode of schizophrenia: the SPHERE Study.Long-acting formulation of a new muscarinic receptor antagonist for the treatment of overactive bladder.An Unexpected Circumstance: Acute Dystonic Reaction in the Setting of Clozapine Administration.Possible long-acting risperidone-induced hypothermia precipitating phenytoin toxicity in an elderly patient.Dosing patterns in Europe: Efficacy and safety of risperidone long-acting injectable in doses of 25, 37.5 and 50 mg.
P2860
Q26747614-E786A351-13B2-45B2-96C6-23A382299952Q30493152-6E958352-9BF1-4D0C-8BB8-730D19D51429Q33821379-62630C63-B436-484C-8B9A-DF5BED549465Q34418847-07A77E72-9397-4C7F-B30A-96CACB90F9E0Q34629537-8D1628EB-1A7A-4308-B628-51D62A5B2AC0Q35143555-8709B534-BD99-4BAA-8F2A-7416B1C8B0F6Q36435931-D3CEF0C6-583D-4559-A365-B8FAC57E7B80Q36845241-9D375F12-ADC8-4F1C-A11C-D990311A399DQ37062563-15EA806C-794F-4CC2-B132-D458974ED4D8Q37226979-A985BAFE-9D43-4798-A0D3-85C81CC361CCQ37356486-10A9601F-53A5-43A5-8E7A-C805A45F69AAQ37672702-27145882-CD01-4386-867A-952CBC51C6A5Q37833061-0EE301A0-E3DA-482B-828F-45482304629BQ38067137-E7EF2CD1-EFA4-41A6-B831-82FD892EE008Q38094683-C7EBEA9C-E5E2-4CCF-BC0A-8DD83192F565Q38815462-6D452A4D-177C-4FE3-B37D-C7307B37E99DQ40335811-CF28642C-2FA7-4AC5-B10F-DBB42A52F697Q41962765-F8DFA3AE-7BA2-4C78-9358-0139294FC155Q42252223-28F98C2F-C1F8-42EF-B3F0-D15D322AC83AQ43107438-5171BCE9-1CB4-45A5-BA50-D682957EAD2FQ43260838-26631A1C-BFD4-4D0A-81FA-9F82ECA8446FQ44023036-257DC0E3-EC2F-4D8E-8C4A-F9F339A63BA2Q50221510-F8ECAC62-4313-4FCA-A7F8-12FBB50DAA8CQ50803501-4C28DF9C-2B58-489A-9426-52F812E50D7CQ51665119-4FD65F50-0DEE-496F-948B-A47079C758FE
P2860
Clinical review of a long-acting, injectable formulation of risperidone.
description
2004 nî lūn-bûn
@nan
2004年の論文
@ja
2004年論文
@yue
2004年論文
@zh-hant
2004年論文
@zh-hk
2004年論文
@zh-mo
2004年論文
@zh-tw
2004年论文
@wuu
2004年论文
@zh
2004年论文
@zh-cn
name
Clinical review of a long-acting, injectable formulation of risperidone.
@ast
Clinical review of a long-acting, injectable formulation of risperidone.
@en
type
label
Clinical review of a long-acting, injectable formulation of risperidone.
@ast
Clinical review of a long-acting, injectable formulation of risperidone.
@en
prefLabel
Clinical review of a long-acting, injectable formulation of risperidone.
@ast
Clinical review of a long-acting, injectable formulation of risperidone.
@en
P1476
Clinical review of a long-acting, injectable formulation of risperidone.
@en
P2093
Erin Danielle Knox
Glen L Stimmel
P304
P356
10.1016/J.CLINTHERA.2004.12.009
P577
2004-12-01T00:00:00Z